We all have come across that one person who has either lost drastic weight with ozempic-style injections or is on that path. Haven’t we?
The rise of GLP-1 receptor agonists, popularly known through drugs
like Ozempic, Wegovy, and Mounjaro has been nothing short of transformative in modern medicine. Originally developed to treat Type 2 diabetes and obesity, these medications are now at the centre of a global weight-loss boom. In India, however, their rapid rise is raising a critical question: are these drugs a medical breakthrough or a growing misuse epidemic?
Dr. Vimal Pahuja, MD and Associate Director of Internal Medicine & Metabolic Physician, Dr. LH Hiranandani Hospital, believes these drugs are “genuinely revolutionary” when used correctly. By mimicking a natural hormone that regulates insulin, appetite, and energy balance, they can significantly improve metabolic health.
But outside clinical settings, a different narrative is unfolding.
From Medical Breakthrough to Cosmetic Shortcut
“India is now witnessing widespread misuse,” says Dr. Pahuja. “The drug is being used as a cosmetic shortcut rather than a medical intervention.”
Fuelled by social media, celebrity culture, and what he describes as a “Bollywood-wedding aesthetic,” weight-loss injections are increasingly being sought for rapid, visible transformation. For many, the idea of health has been replaced by the urgency to look lean fast.
“These injections promise quick results, often within weeks, for people unwilling to undergo sustained behavioural or nutritional change,” he explains. “This reflects a concerning medicalisation of vanity.”
A Drug for the Privileged?
The accessibility of these drugs in India reveals another troubling dimension, inequality.
“Access is heavily skewed towards affluence,” notes Dr Pahuja. Monthly treatment costs can range between ₹70,000 and ₹90,000, placing them far beyond the reach of most patients who actually need them.
At the same time, supply chains are being diverted. “Stock meant for hospital diabetes programmes is increasingly finding its way into elite wellness clinics catering to aesthetic demands,” he says.
The result? Patients with Type 2 diabetes, who rely on these medications to manage blood sugar and reduce life-threatening complications are facing shortages and rising costs.
“For them, it’s not about appearance, it’s about survival,” Dr. Pahuja adds. “The cosmetic boom has effectively hijacked their medical lifeline.”
The Hidden Risks No One Talks About
While the promise of quick weight loss is appealing, the risks of unsupervised use are far from trivial.
“These are potent hormonal modulators, not cosmetic agents,” warns Dr. Pahuja.
Physically, misuse can lead to:
Severe gastrointestinal distress
Dehydration
Pancreatitis
Acute kidney injury
Rapid muscle loss and facial hollowing, often referred to as “Ozempic face”
Psychologically, the effects can be just as serious. “Stopping the drug abruptly can trigger rebound hunger, rapid weight regain, and emotional distress, even depression,” he explains.
Without proper nutritional planning and exercise, patients may end up metabolically weaker, despite losing weight.
Are We Replacing Discipline With Dependency?
Perhaps the most significant concern is what this trend signals for the future of public health.
“India is moving towards a pharmacological dependency model, fixing weight chemically rather than behaviourally,” says Dr. Pahuja.
In a country already grappling with rising obesity, diabetes, and lifestyle disorders, this shift could have long-term consequences. Instead of addressing root causes, processed diets, sedentary lifestyles, poor sleep, and chronic stress, there is an increasing reliance on pharmaceutical fixes.
“If this continues, we risk creating a generation that is hormonally controlled rather than self-regulated,” he warns.
The Rise of ‘Pre-Wedding Weight Loss’
One of the most telling indicators of this cultural shift is the surge in pre-wedding consultations.
“In many clinics, ‘pre-wedding weight loss’ has become a distinct category,” says Dr. Pahuja. Prospective brides and grooms are increasingly requesting maximum doses to achieve rapid results within just a few weeks.
“This reflects how deeply body image anxiety has permeated even life milestones like marriage,” he adds.
GLP-1 drugs remain one of the most powerful tools in modern medicine for managing obesity and diabetes. But as their use expands beyond clinical boundaries, so do the risks, medical, ethical, and societal.
“Used correctly, these drugs are a miracle,” says Dr. Pahuja. “But when turned into vanity medicine, they become misuse.”
The challenge for India now is clear: balance access with accountability and ensure that innovation in healthcare does not get overshadowed by impatience and privilege.
